医学
接种疫苗
抗体
人口
免疫学
2019年冠状病毒病(COVID-19)
内科学
疾病
传染病(医学专业)
环境卫生
作者
Michel Obéid,Madeleine Suffiotti,Céline Pellaton,Hasna Bouchaab,Anne Cairoli,Vanja Salvadé,Caroline Razafinjatovo,Rosemary Hottinger,Catherine Pythoud,Lucie Coutechier,Laura Molinari,Didier Trono,Camillo Ribi,Raphaël Gottardo,Craig Fenwick,Manuel Pascual,Michel A. Duchosal,Solange Peters,Giuseppe Pantaleo
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2022-03-10
卷期号:8 (5): e220446-e220446
被引量:63
标识
DOI:10.1001/jamaoncol.2022.0446
摘要
There are limited comparative data on the durability of neutralizing antibody (nAb) responses elicited by messenger RNA (mRNA) vaccines against the SARS-CoV-2 variants of concern (VOCs) in immunocompromised patients and healthy controls.
科研通智能强力驱动
Strongly Powered by AbleSci AI